FIELD: ophthalmology.
SUBSTANCE: invention relates to ophthalmology and can be used to identify a group of children at high risk of developing retinopathy of prematurity with an unfavorable course of the disease. For this, in premature infants with a post-conceptual age of 32-35 weeks, the serotonin content is determined in the blood plasma. When its level is equal to or below 14.0 pg/ml, the development of retinopathy of prematurity is predicted.
EFFECT: invention makes it possible to predict the risk of developing retinopathy of premature infants with an unfavorable course of the disease in order to adjust the tactics of managing such patients and to reduce the number of examinations of premature infants with a lower risk of developing this disease.
1 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE DEVELOPMENT OF EXTRARETINAL VASOPROLIFERATION IN EXPERIMENTAL RETINOPATHY OF PREMATURITY (ROP) | 2020 |
|
RU2751007C1 |
| METHOD FOR PREDICTION OF DEVELOPING THRESHOLD RETINOPATHY OF PREMATURITY IN INFANTS HAVING NO OPHTHALMIC SIGNS OF DISEASE | 2013 |
|
RU2526827C1 |
| METHOD OF EARLY DIAGNOSIS OF FAMILIAL EXUDATIVE RETINOPATHY IN CHILDREN | 2022 |
|
RU2796894C1 |
| METHOD FOR PREDICTION OF RISK OF LATE RETINAL DETACHMENT IN CHILDREN WITH CICATRICAL RETINOPATHY OF PREMATURITY | 2013 |
|
RU2540504C1 |
| METHOD FOR PREDICTION OF LASER COAGULATION NECESSITY FOR PREMATURE RETINOPATHY | 2016 |
|
RU2630614C1 |
| PREDICTION METHOD OF PREMATURE RETINOPATHY ACTIVE PHASE DEVELOPMENT | 2016 |
|
RU2618395C1 |
| METHOD FOR PREDICTION OF RETINOPATHY OF PREMATURITY | 2015 |
|
RU2582049C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE TYPE OF STAGE 2 OF ACTIVE RETINOPATHY OF PREMATURITY ACCORDING TO ULTRASONIC BIOMICROSCOPY DATA | 2023 |
|
RU2822590C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF RETINOPATHY IN PREMATURE BABIES | 2001 |
|
RU2216740C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF POSTERIOR AGGRESSIVE RETINOPATHY IN PREMATURE INFANTS | 2010 |
|
RU2441593C1 |
